fda compounding semaglutide enforcement november 2025 GLP-1 Weight Loss Drug in 2025: State Attorneys General Step into a Growing Regulatory Gap FDA issued 25 warning letters

Consider Microdosing Some users experiment with microdosing retatrutide at sub-clinical doses (0.251mg/week)

Key takeaways: Restless leg syndrome (RLS) and Periodic Limb Movement Disorder (PLMD) can disrupt sleep and have significant long-term effects on your health

Understanding Telogen Effluvium in the Context of Retatrutide Use The shedding people describe after using retatrutide typically matches telogen effluvium, a diffuse thinning across the whole scalp rather than a receding or bald patch

Starting Retatrutide: Dosing and the Titration Schedule Retatrutide is given as a once-weekly subcutaneous injection, starting at 2 mg in Phase 2 protocols and escalating to 812 mg

If you want to see whether a personalized program fits your goals, complete the free assessment quiz

(These are the active ingredients used in brand-name weight-loss medications.) Although they differ slightly, these drugs both work by mimicking gut hormones associated with appetite